vs
Elastic N.V.（ESTC）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是Elastic N.V.的1.5倍（$622.0M vs $423.5M），Royalty Pharma plc净利率更高（34.4% vs -12.1%，领先46.5%），Elastic N.V.同比增速更快（15.9% vs 4.8%），过去两年Elastic N.V.的营收复合增速更高（13.6% vs 4.6%）
Elastic是荷美合资软件企业，2012年成立于荷兰阿姆斯特丹，运营总部分设于荷兰及美国加利福尼亚州旧金山市，于纽交所上市。公司提供企业级搜索、可观测性、网络安全平台，可支持用户实现大规模数据搜索分析、系统性能监测及异常检测。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
ESTC vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.5倍
$423.5M
营收增速更快
ESTC
高出11.1%
4.8%
净利率更高
RPRX
高出46.5%
-12.1%
两年增速更快
ESTC
近两年复合增速
4.6%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $423.5M | $622.0M |
| 净利润 | $-51.3M | $214.2M |
| 毛利率 | 75.9% | — |
| 营业利润率 | -1.9% | 62.4% |
| 净利率 | -12.1% | 34.4% |
| 营收同比 | 15.9% | 4.8% |
| 净利润同比 | -101.5% | 2.9% |
| 每股收益（稀释后） | $-0.48 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESTCRPRX
| Q4 25 | $423.5M | $622.0M | ||
| Q3 25 | $415.3M | $609.3M | ||
| Q2 25 | $388.4M | $578.7M | ||
| Q1 25 | $382.1M | $568.2M | ||
| Q4 24 | $365.4M | $593.6M | ||
| Q3 24 | $347.4M | $564.7M | ||
| Q2 24 | $335.0M | $537.3M | ||
| Q1 24 | $328.0M | $568.0M |
净利润ESTCRPRX
| Q4 25 | $-51.3M | $214.2M | ||
| Q3 25 | $-24.6M | $288.2M | ||
| Q2 25 | $-16.4M | $30.2M | ||
| Q1 25 | $-17.1M | $238.3M | ||
| Q4 24 | $-25.4M | $208.2M | ||
| Q3 24 | $-49.2M | $544.0M | ||
| Q2 24 | $-41.1M | $102.0M | ||
| Q1 24 | $176.1M | $4.8M |
毛利率ESTCRPRX
| Q4 25 | 75.9% | — | ||
| Q3 25 | 76.7% | — | ||
| Q2 25 | 74.8% | — | ||
| Q1 25 | 74.6% | — | ||
| Q4 24 | 74.5% | — | ||
| Q3 24 | 73.6% | — | ||
| Q2 24 | 73.8% | — | ||
| Q1 24 | 74.2% | — |
营业利润率ESTCRPRX
| Q4 25 | -1.9% | 62.4% | ||
| Q3 25 | -2.3% | 70.1% | ||
| Q2 25 | -3.1% | 36.3% | ||
| Q1 25 | -1.2% | 94.0% | ||
| Q4 24 | -1.2% | 60.9% | ||
| Q3 24 | -9.7% | — | ||
| Q2 24 | -13.6% | 50.2% | ||
| Q1 24 | -8.1% | -13.0% |
净利率ESTCRPRX
| Q4 25 | -12.1% | 34.4% | ||
| Q3 25 | -5.9% | 47.3% | ||
| Q2 25 | -4.2% | 5.2% | ||
| Q1 25 | -4.5% | 41.9% | ||
| Q4 24 | -7.0% | 35.1% | ||
| Q3 24 | -14.2% | 96.3% | ||
| Q2 24 | -12.3% | 19.0% | ||
| Q1 24 | 53.7% | 0.8% |
每股收益（稀释后）ESTCRPRX
| Q4 25 | $-0.48 | $0.49 | ||
| Q3 25 | $-0.23 | $0.67 | ||
| Q2 25 | $-0.15 | $0.07 | ||
| Q1 25 | $-0.16 | $0.55 | ||
| Q4 24 | $-0.25 | $0.46 | ||
| Q3 24 | $-0.48 | $1.21 | ||
| Q2 24 | $-0.35 | $0.23 | ||
| Q1 24 | $1.69 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.4B | $618.7M |
| 总债务越低越好 | $570.3M | $9.0B |
| 股东权益账面价值 | $891.1M | $9.7B |
| 总资产 | $2.5B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.64× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资ESTCRPRX
| Q4 25 | $1.4B | $618.7M | ||
| Q3 25 | $1.5B | $938.9M | ||
| Q2 25 | $1.4B | $631.9M | ||
| Q1 25 | $584.0M | $1.1B | ||
| Q4 24 | $658.5M | $929.0M | ||
| Q3 24 | $594.9M | $950.1M | ||
| Q2 24 | $1.1B | $1.8B | ||
| Q1 24 | $526.9M | $843.0M |
总债务ESTCRPRX
| Q4 25 | $570.3M | $9.0B | ||
| Q3 25 | $570.0M | $8.9B | ||
| Q2 25 | $569.7M | $8.0B | ||
| Q1 25 | $569.4M | $7.6B | ||
| Q4 24 | $569.2M | $7.6B | ||
| Q3 24 | $568.9M | $7.6B | ||
| Q2 24 | $568.6M | $7.6B | ||
| Q1 24 | $568.3M | $6.1B |
股东权益ESTCRPRX
| Q4 25 | $891.1M | $9.7B | ||
| Q3 25 | $971.4M | $9.6B | ||
| Q2 25 | $927.2M | $9.5B | ||
| Q1 25 | $859.1M | $9.8B | ||
| Q4 24 | $811.5M | $10.3B | ||
| Q3 24 | $759.4M | $10.3B | ||
| Q2 24 | $738.2M | $9.8B | ||
| Q1 24 | $707.8M | $9.9B |
总资产ESTCRPRX
| Q4 25 | $2.5B | $19.6B | ||
| Q3 25 | $2.5B | $19.3B | ||
| Q2 25 | $2.6B | $18.3B | ||
| Q1 25 | $2.3B | $17.6B | ||
| Q4 24 | $2.2B | $18.2B | ||
| Q3 24 | $2.2B | $18.0B | ||
| Q2 24 | $2.2B | $17.7B | ||
| Q1 24 | $2.1B | $16.1B |
负债/权益比ESTCRPRX
| Q4 25 | 0.64× | 0.92× | ||
| Q3 25 | 0.59× | 0.93× | ||
| Q2 25 | 0.61× | 0.84× | ||
| Q1 25 | 0.66× | 0.78× | ||
| Q4 24 | 0.70× | 0.74× | ||
| Q3 24 | 0.75× | 0.74× | ||
| Q2 24 | 0.77× | 0.78× | ||
| Q1 24 | 0.80× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $26.6M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $26.0M | — |
| 自由现金流率自由现金流/营收 | 6.1% | — |
| 资本支出强度资本支出/营收 | 0.1% | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | $302.3M | — |
8季度趋势，按日历期对齐
经营现金流ESTCRPRX
| Q4 25 | $26.6M | $827.1M | ||
| Q3 25 | $104.8M | $702.6M | ||
| Q2 25 | $87.0M | $364.0M | ||
| Q1 25 | $88.1M | $596.1M | ||
| Q4 24 | $38.4M | $742.5M | ||
| Q3 24 | $52.8M | $703.6M | ||
| Q2 24 | $60.9M | $658.2M | ||
| Q1 24 | $52.4M | $664.6M |
自由现金流ESTCRPRX
| Q4 25 | $26.0M | — | ||
| Q3 25 | $104.2M | — | ||
| Q2 25 | $84.9M | — | ||
| Q1 25 | $87.3M | — | ||
| Q4 24 | $37.7M | — | ||
| Q3 24 | $52.0M | — | ||
| Q2 24 | $60.1M | — | ||
| Q1 24 | $51.3M | — |
自由现金流率ESTCRPRX
| Q4 25 | 6.1% | — | ||
| Q3 25 | 25.1% | — | ||
| Q2 25 | 21.8% | — | ||
| Q1 25 | 22.8% | — | ||
| Q4 24 | 10.3% | — | ||
| Q3 24 | 15.0% | — | ||
| Q2 24 | 17.9% | — | ||
| Q1 24 | 15.6% | — |
资本支出强度ESTCRPRX
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.2% | — | ||
| Q2 25 | 0.5% | — | ||
| Q1 25 | 0.2% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | 0.3% | — |
现金转化率ESTCRPRX
| Q4 25 | — | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | — | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | — | 6.45× | ||
| Q1 24 | 0.30× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESTC
| Self Managed Subscription | $192.0M | 45% |
| Saa S Self Managed Annual | $156.9M | 37% |
| Saa S Self Managed Monthly | $48.8M | 12% |
| Professional Services | $25.8M | 6% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
